John Barnard

Managing Director of Pearl Street Venture Funds and Co-founder of Apexian Pharmaceuticals, Inc. with extensive experience developing and exiting early-stage companies. Former investor and Board advisor to Colucid Pharmaceuticals, Inc. acquired by Eli Lilly and Company for $960M.